JAMES PEYER, PH.D.
Founder of Apollo Ventures.
“Investing in breakthrough technologies for treating age-related disease.”
james was only sixteen when he decided he would dedicate his life to preventing the diseases of age. He has been a scientist, entrepreneur, and advisor to biotechs and pharma companies, always with a specialization for developing new classes of therapeutics. James founded Apollo to support biotech entrepreneurs strategically, scientifically, and financially as they create the next generation of medicines. James Peyer is a Partner at Apollo Ventures, an early stage life science investment fund focused on breakthrough technologies for treating age-related disease. Apollo works with amazing scientists on groundbreaking therapeutics by investing at the seed stage or helping to start brand new companies. We invest substantial funds to ensure that our portfolio companies can do the best science to advance their programs to the next stage. Before Apollo, James worked with McKinsey and Company in New York, where he focused on building new biotech companies and developing strategies for valuating and commercializing cell therapies. His focus was on clinical technologies with novel modes of action and substantial development challenges. During his PhD studies, James cofounded and ran Genotyp, a biotech education startup which became the first biotech company to be funded through Kickstarter.com. He earned his doctorate in stem cell biology in the laboratory of Dr. Sean Morrison at University of Texas Southwestern in Dallas, where he was a National Science Foundation GRFP Fellow. For his thesis he invented new ways of statistically analyzing three dimensional relationships between stem cells and their environments. James earned his bachelor’s with special honors from the University of Chicago with a degree in Immunology.